Janardan Khandekar to Survival Analysis
This is a "connection" page, showing publications Janardan Khandekar has written about Survival Analysis.
Connection Strength
0.042
-
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Eur Urol. 2017 05; 71(5):740-747.
Score: 0.026
-
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885. Am J Clin Oncol. 2001 Apr; 24(2):150-4.
Score: 0.009
-
Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93). Am J Clin Oncol. 1998 Dec; 21(6):553-6.
Score: 0.007